[
1. Surbatovic M, Vojvodic D, Khan W. Immune response in critically ill patients. Mediators Inflamm 2018; 2018:9524315.10.1155/2018/9524315607940530116156
]Search in Google Scholar
[
2. Diaz-Alvarez L, Ortega E. The many roles of galectin-3, a multifaceted molecule, in innate immune responses against pathogens. Mediators Inflamm 2017; 2017:9247574.10.1155/2017/9247574545777328607536
]Search in Google Scholar
[
3. Vasta GR. Galectins as pattern recognition receptors: structure, function and evolution. Adv Exp Med Biol 2012; 946:21-36.10.1007/978-1-4614-0106-3_2342993821948360
]Search in Google Scholar
[
4. Nio-Kobayashi J. Tissue- and cell-specific localization of galectins, beta-galactose-binding animal lectins, and their potential functions in health and disease. Anat Sci Int 2017; 92:25-36.10.1007/s12565-016-0366-627590897
]Search in Google Scholar
[
5. Djordjevic D, Pejovic J, Surbatovic M, et al. Prognostic value and daily trend of interleukin-6, neutrophil CD64 expression, C-reactive protein and lipopolysaccharide-binding protein in critically ill patients: reliable predictors of outcome or not? J Med Biochem 2015; 34(4):431-9.
]Search in Google Scholar
[
6. Surbatovic M, Radakovic S. Tumor necrosis factor-(alpha) levels in severe acute pancreatitis: is there predictive value regarding severity and outcome? J Clin Gastroenterol 2013; 47:637-43.
]Search in Google Scholar
[
7. Djordjevic D, Rondovic G, Surbatovic M, et al. Neutro-phil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Mean Platelet Volume-to-Platelet Count Ratio as biomarkers in critically ill and injured patients: which ratio to choose to predict outcome and nature of bacteremia? Mediators Inflamm 2018; 2018:3758068.
]Search in Google Scholar
[
8. Singer M, Deutschman CS, Seymour CW, et al.The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315: 801-810.10.1001/jama.2016.0287496857426903338
]Search in Google Scholar
[
9. Miller MC, Ippel H, Suylen D, et al. Binding of polysaccharides to human galectin – 3 at a noncanonical site in its carbohydrate recognition domain. Glycobiology 2016; 26:88-99.10.1093/glycob/cwv073485171626646771
]Search in Google Scholar
[
10. Ippel H, Miller MC, Vertesy S, et al. Intra- and intermolecular interactions of human galectin – 3: assessment by full-assignment-based NMR. Glycobiology 2016; 26:888-903.10.1093/glycob/cww021501804426911284
]Search in Google Scholar
[
11. Sato S, Bhaumik P, St-Pierre G, et al. Role of galectin – 3 in the initial control of Leishmania infection. Crit Rev Immunol 2014; 34:147-175.10.1615/CritRevImmunol.201401015424940913
]Search in Google Scholar
[
12. Sato S, St-Pierre C, Bhaumik P, et al. Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs). Immunol Rev 2009; 230:172-18710.1111/j.1600-065X.2009.00790.x19594636
]Search in Google Scholar
[
13. Quattroni P, Li Y, Lucchesi D, et al. Galectin-3 binds Neisseria meningitidis and increases interaction with phagocytic cells. Cell Microbiol 2012; 14:1657-1675.10.1111/j.1462-5822.2012.01838.x374981422827322
]Search in Google Scholar
[
14. Chung AW, Sieling PA, Schenk M, et al. Galectin – 3 regulates the innate immune response of human monocytes. J Infect Dis 2013; 207:947-956.10.1093/infdis/jis920357144223255567
]Search in Google Scholar
[
15. Foo SS, Reading PC, Jaillon S, et al. Pentraxins and collectins: friend or foe during pathogen invasion? Trends Microbiol 2015; 23:799-811
]Search in Google Scholar
[
16. Chen HY, Weng IC, Hong MH, et al. Galectins as bacterial sensors in the host innate response. Curr Opin Microbiol 2014; 17:75-8110.1016/j.mib.2013.11.00624581696
]Search in Google Scholar
[
17. Baseras B, Gaida MM, Kahle N, et al. Galectin – 3 inhibits the chemotaxis of human polymorphonuclear neutrophils in vitro. Immunobiology 2012; 217:83-90.10.1016/j.imbio.2011.07.03121899917
]Search in Google Scholar
[
18. Wright RD, Souza PR, Flak MB, et al. Galectin – 3 – null mice display defective neutrophil clearance during acute inflammation. J Leukoc Biol 2017; 101:717-726.10.1189/jlb.3A0116-026RR529585027733579
]Search in Google Scholar
[
19. Mishra BB, Li Q, Steichen AL, et al. Galectin-3 functions as an alarmin: pathogenic role for sepsis development in murine respiratory tularemia. PLoS One 2013; 8:e59616.10.1371/journal.pone.0059616360390823527230
]Search in Google Scholar
[
20. Burguillos MA, Svensson M, Schulte T, et al. Microglia-secreted galectin – 3 acts as a Toll-like receptor 4 ligand and contributes to microglial activation. Cell Rep 2015; 10:1626-1638.10.1016/j.celrep.2015.02.01225753426
]Search in Google Scholar
[
21. Chen SS, Sun LW, Brickner H, et al. Downregulating galectin – 3 inhibits proinflammatory cytokine production by human monocyte – derived dendritic cells via RNA interference. Cell Immunol 2015; 294:44-5310.1016/j.cellimm.2015.01.017470470425684095
]Search in Google Scholar
[
22. ten Oever J, Giamarellos-Bourboulis EJ, van de Veer-donk FL, et al. Circulating galectin-3 in infections and non-infectious inflammatory diseases. Eur J Clin Microbiol Infect Dis 2013; 32:1605-1610.10.1007/s10096-013-1919-423828453
]Search in Google Scholar
[
23. Mueller T, Leitner I, Egger M, et al. Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases. Clin Chim Acta 2015; 445:155-160.10.1016/j.cca.2015.03.03325850080
]Search in Google Scholar
[
24. Dieplinger B, Egger M, Leitner I, et al. Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patients. J Crit Care 2016; 34:38-45.10.1016/j.jcrc.2016.03.02027288608
]Search in Google Scholar
[
25. Kim H, Hur M, Moon HW, et al. Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis. Ann Intensive Care 2017; 7:2710.1186/s13613-017-0252-y534078928271449
]Search in Google Scholar
[
26. Coromilas E, Que-Xu EC, Moore D, et al. Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation. BMC Cardiovasc Disord 2016; 16:138.10.1186/s12872-016-0298-z490670427301475
]Search in Google Scholar
[
27. Desmedt V, Desmedt S, Delanghe JR, et al. Galectin – 3 in Renal Pathology: More Than Just an Innocent Bystander. Am J Nephrol 2016; 43:305-317.10.1159/00044637627166158
]Search in Google Scholar
[
28. Saccon F, Gatto M, Ghirardello A, et al. Role of galectin – 3 in autoimmune and non-autoimmune nephropathies. Autoimmun Rev 2017; 16:34-47.10.1016/j.autrev.2016.09.02327666815
]Search in Google Scholar
[
29. Fritsch K, Mernberger M, Nist A, et al. Galectin-3 interacts with components of the nuclear ribonucleoprotein complex. BMC Cancer 2016; 16:502.10.1186/s12885-016-2546-0495236427435226
]Search in Google Scholar
[
30. Wang L, Guo XL. Molecular regulation of galectin-3 expression and therapeutic implication in cancer progression. Biomed Pharmacother 2016; 78:165-171.10.1016/j.biopha.2016.01.01426898438
]Search in Google Scholar
